SLC5A2 and type 2 diabetes mellitus: SGLT2, which is located on the apical membrane of renal tubular epithelial cells, is the principal contributor to the reabsorption of filtered glucose, and SGLT2 inhibitors are now a well-defined class of anti-hyperglycemic agents for type 2 diabetes.